Discriminating MGMT Promoter Methylation Status in Patients with Glioblastoma Employing Amide Proton Transfer-Weighted MRI Metrics

OBJECTIVES: To explore the feasibility of using amide proton transfer-weighted (APTw) MRI metrics as surrogate biomarkers to identify the O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status in glioblastoma (GBM). METHODS: Eighteen newly diagnosed GBM patients, who were previous...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Eur Radiol
Glavni autori: Jiang, Shanshan, Rui, Qihong, Wang, Yu, Heo, Hye-Young, Zou, Tianyu, Yu, Hao, Zhang, Yi, Wang, Xianlong, Du, Yongxing, Wen, Xinrui, Chen, Fangyao, Wang, Jihong, Eberhart, Charles G., Zhou, Jinyuan, Wen, Zhibo
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5884703/
https://ncbi.nlm.nih.gov/pubmed/29234914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00330-017-5182-4
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items